Stay updated on CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial page.

Latest updates to the CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial page
- Check4 days agoChange DetectedThe page now shows a formal 403 Forbidden error page with the standard header and footer, replacing the previous generic 'This site can't be reached' message.SummaryDifference100%

- Check11 days agoChange DetectedRevision: v3.7.0 was added, marking a new version of the study record. The Study Documents section had many entries removed (PDFs, plans, IPD sharing information, and related items), indicating a cleanup of downloadable materials.SummaryDifference20%

- Check18 days agoChange DetectedAdditional related topics such as Rheumatoid arthritis and MedlinePlus Genetics were added to the page's related topics section, expanding the contextual links to associated medical topics.SummaryDifference0.2%

- Check25 days agoChange DetectedDeleted the explicit disease tag 'Rheumatoid arthritis' and the related topics section header 'MedlinePlus Genetics' from the study page, removing direct condition tagging and a gateway to related educational resources. This affects how users discover and navigate the page when filtering by condition or seeking related materials.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now shows revision: v3.6.6, replacing v3.6.5, indicating a deployment update. This update does not alter the study details or user interactions on the page.SummaryDifference0.1%

- Check39 days agoChange DetectedThe entry ‘2016 ( U.S. NIH Grant/Contract )’ was added to the Other Study ID Numbers section. This reflects the NIH funding acknowledgment associated with the study.SummaryDifference0.1%

Stay in the know with updates to CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial page.